Historically significant events in the discovery of RANK/RANKL/OPG

World Journal of Orthopedics

Volumn 4, Issue 4, 2013, Pages 186-197

  Martin, John T ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

Bone biology; Osteoclasts; Osteoprotegerin; Receptor activator of nuclear factor B; Receptor activator of nuclear factor B ligand

Indexed keywords

EID: 84892981877     PISSN: None     EISSN: 22185836     Source Type: Journal    
DOI: 10.5312/wjo.v4.i4.186     Document Type: Article

References (90)

1. Kolliker A. Die Normal Resorption des Knochengewebes und ihre Bedeutung die Entstehung der Typischen Knochenformen. Liepzig: Vogel FCW, 1873
2. Holtrop ME, King GJ. The ultrastructure of the osteoclast and its functional implications. Clin Orthop Relat Res 1977; (123): 177-196 [PMID: 856515]
3. Arnett TR, Dempster DW. Protons and osteoclasts. J Bone Miner Res 1990; 5: 1099-1103 [PMID: 2176771 DOI: 10.1002/jbmr.5650051102]
4. Vaes G. Cellular biology and biochemical mechanism of bone resorption. A review of recent developments on the formation, activation, and mode of action of osteoclasts. Clin Orthop Relat Res 1988; (231): 239-271 [PMID: 3286076]
5. Baron R. Molecular mechanisms of bone resorption: therapeutic implications. Rev Rhum Engl Ed 1996; 63: 633-638 [PMID: 8953663]
6. Nicholson GC, Moseley JM, Sexton PM, Mendelsohn FA, Martin TJ. Abundant calcitonin receptors in isolated rat osteoclasts. Biochemical and autoradiographic characterization. J Clin Invest 1986; 78: 355-360 [PMID: 3016026 DOI: 10.1172/JCI112584]
7. Takahashi N, Akatsu T, Sasaki T, Nicholson GC, Moseley JM, Martin TJ, Suda T. Induction of calcitonin receptors by 1 alpha, 25-dihydroxyvitamin D3 in osteoclast-like multinucleated cells formed from mouse bone marrow cells. Endocrinology 1988; 123: 1504-1510 [PMID: 2841098 DOI: 10.1210/endo-123-3-1504]
8. Tonna EA. Periosteal osteoclasts, skeletal development and ageing. Nature 1960; 185: 405-407 [PMID: 13838818 DOI: 10.1038/185405a0]
9. Fornadley JA, Parker GS, Rickman LS, Paparello S. Candida myositis manifesting as a discrete neck mass. Otolaryngol Head Neck Surg 1990; 102: 74-76 [PMID: 2106120 DOI: 10.1083/jcb.14.3.357]
10. Rasmussen HP. The Physiological Basis of Metabolic Bone Disease. Baltimore: Williams and Wilkins Waverley Press, 1974
11. Kahn AJ, Simmons DJ. Investigation of cell lineage in bone using a chimaera of chick and quial embryonic tissue. Nature 1975; 258: 325-327 [PMID: 1196357 DOI: 10.1038/258325a0]
12. Walker DG. Bone resorption restored in osteopetrotic mice by transplants of normal bone marrow and spleen cells. Science 1975; 190: 784-785 [PMID: 1105786 DOI: 10.1126/science.1105786]
13. Nijweide PJ, Burger EH, Feyen JH. Cells of bone: proliferation, differentiation, and hormonal regulation. Physiol Rev 1986; 66: 855-886 [PMID: 3532144]
14. Owen M. Cellular Dynamics of Bone. In: Biochemistry and Physiology of Bone. 2nd ed. Bourne GH, editor. New York: Academic Press, 1971: 271-297
15. Chambers TJ. The cellular basis of bone resorption. Clin Orthop Relat Res 1980; (151): 283-293 [PMID: 7418318]
16. Peck WA, Birge SJ, Fedak SA. Bone cells: biochemical and biological studies after enzymatic isolation. Science 1964; 146: 1476-1477 [PMID: 14208576 DOI: 10.1126/science.146.3650.1476]
17. Steuden I, Radzikowski C, Zak-Nejmark T. Serological identification of viral and virus-related antigens on DBA/2 mouse leukemia lymphocytes. Arch Immunol Ther Exp (Warsz) 1979; 27: 187-207 [PMID: 220930 DOI: 10.1073/pnas.48.7.1184]
18. Taunton OD, Roth J, Pastan I. Studies on the adrenocorticotropic hormone-activated adenyl cyclase of a functional adrenal tumor. J Biol Chem 1969; 244: 247-253 [PMID: 4304299]
19. Martin TJ, Ingleton PM, Underwood JC, Michelangeli VP, Hunt NH, Melick RA. Parathyroid hormone-responsive adenylate cyclase in induced transplantable osteogenic rat sarcoma. Nature 1976; 260: 436-438 [PMID: 1062678 DOI: 10.1038/260436a0]
20. Atkins D, Hunt NH, Ingleton PM, Martin TJ. Rat osteogenic sarcoma cells: isolation and effects of hormones on the production of cyclic AMP and cyclic GMP. Endocrinology 1977; 101: 555-561 [PMID: 195798 DOI: 10.1210/endo-101-2-555]
21. Atkins D, Martin TJ. Rat osteogenic sarcoma cells: effects of some prostaglandins, their metabolites and analogues on cyclic AMP production. Prostaglandins 1977; 13: 861-871 [PMID: 194286 DOI: 10.1016/0090-6980(77)90216-7]
22. Crawford A, Hunt NH, Dawborn JK, Michelangeli VP, Martin TJ. Membranes from a transplantable osteogenic sarcoma responsive to parathyroid hormone and prostaglandins: regulation of adenylate cyclase and of hormone metabolism. J Endocrinol 1978; 77: 213-224 [PMID: 275436 DOI: 10.1677/joe.0.0770213]
23. Partridge NC, Alcorn D, Michelangeli VP, Kemp BE, Ryan GB, Martin TJ. Functional properties of hormonally responsive cultured normal and malignant rat osteoblastic cells. Endocrinology 1981; 108: 213-219 [PMID: 6936260 DOI: 10.1210/endo-108-1-213]
24. Partridge NC, Alcorn D, Michelangeli VP, Ryan G, Martin TJ. Morphological and biochemical characterization of four clonal osteogenic sarcoma cell lines of rat origin. Cancer Res 1983; 43: 4308-4314 [PMID: 6575864]
25. Majeska RJ, Rodan SB, Rodan GA. Parathyroid hormoneresponsive clonal cell lines from rat osteosarcoma. Endocrinology 1980; 107: 1494-1503 [PMID: 6968673 DOI: 10.1210/endo-107-5-1494]
26. Majeska RJ, Rodan SB, Rodan GA. Maintenance of parathyroid hormone response in clonal rat osteosarcoma lines. Exp Cell Res 1978; 111: 465-468 [PMID: 272288 DOI: 10.1016/0014-4827(78)90193-3]
27. Luben RA, Wong GL, Cohn DV. Biochemical characterization with parathormone and calcitonin of isolated bone cells: provisional identification of osteoclasts and osteoblasts. Endocrinology 1976; 99: 526-534 [PMID: 182458 DOI: 10.1210/endo-99-2-526]
28. Wong GL, Luben RA, Cohn DV. 1,25-dihydroxycholecalciferol and parathormone: effects on isolated osteoclast-like and osteoblast-like cells. Science 1977; 197: 663-665 [PMID: 195343 DOI: 10.1126/science.195343]
29. Crawford A, Atkins D, Martin TJ. Rat osteogenic sarcoma cells: comparison of the effects of prostaglandins E1, E2, I2 (prostacyclin), 6-keto F1alpha and thromboxane B2 on cyclic AMP production and adenylate cyclase activity. Biochem Biophys Res Commun 1978; 82: 1195-1201 [PMID: 212039 DOI: 10.1016/0006-291X(78)90313-3]
30. Partridge NC, Kemp BE, Livesey SA, Martin TJ. Activity ratio measurements reflect intracellular activation of adenosine 3',5'-monophosphate-dependent protein kinase in osteoblasts. Endocrinology 1982; 111: 178-183 [PMID: 6282567 DOI: 10.1210/endo-111-1-178]
31. Klein DC, Raisz LG. Prostaglandins: stimulation of bone resorption in tissue culture. Endocrinology 1970; 86: 1436-1440 [PMID: 4315103 DOI: 10.1210/endo-86-6-1436]
32. Tashjian AH, Tice JE, Sides K. Biological activities of prostaglandin analogues and metabolites on bone in organ culture. Nature 1977; 266: 645-647 [PMID: 558525 DOI: 10.1038/266645a0]
33. Bolas KC, Bellingham WP, Martin GM. Aversive properties of cycloheximide versus memory inhibition in chickens' formation of visually cued food aversions. Pharmacol Biochem Behav 1979; 10: 251-254 [PMID: 450935]
34. Greaves M, Ibbotson KJ, Atkins D, Martin TJ. Prostaglandins as mediators of bone resorption in renal and breast tumours. Clin Sci (Lond) 1980; 58: 201-210 [PMID: 7363561]
35. Rodan GA, Martin TJ. Role of osteoblasts in hormonal control of bone resorption--a hypothesis. Calcif Tissue Int 1981; 33: 349-351 [PMID: 6271355 DOI: 10.1007/BF02409454]
36. Jones SJ, Boyde A. Experimental study of changes in osteoblastic shape induced by calcitonin and parathyroid extract in an organ culture system. Cell Tissue Res 1976; 169: 499-465 [PMID: 991197 DOI: 10.1007/BF00218146]
37. Jones SJ, Boyde A. Morphological changes of osteoblasts in vitro. Cell Tissue Res 1976; 166: 101-107 [PMID: 1248034 DOI: 10.1007/BF00215129]
38. Miller SS, Wolf AM, Arnaud CD. Bone cells in culture: morphologic transformation by hormones. Science 1976; 192: 1340-1343 [PMID: 1273593 DOI: 10.1126/science.1273593]
39. Martin TJ. Drug and hormone effects on calcium release from bone. Pharmacol Ther 1983; 21: 209-228 [PMID: 6353442 DOI: 10.1016/0163-7258(83)90073-6]
40. Belanger LF, Robichon J. Parathormone-induced osteolysis in dogs. a microradiographic and alpharadiographic survey. J Bone Joint Surg Am 1964; 46: 1008-1012 [PMID: 14192496]
41. Bélanger LF. Osteocytic osteolysis. Calcif Tissue Res 1969; 4: 1-12 [PMID: 4310125 DOI: 10.1007/BF02279101]
42. Heller-Steinberg M. Ground substance, bone salts, and cellular activity in bone formation and destruction. Am J Anat 1951; 89: 347-379 [PMID: 14894444 DOI: 10.1002/aja.1000890302]
43. Boyde A, Ali NN, Jones SJ. Resorption of dentine by isolated osteoclasts in vitro. Br Dent J 1984; 156: 216-220 [PMID: 6584143 DOI: 10.1038/sj.bdj.4805313]
44. Chambers TJ. Osteoblasts release osteoclasts from calcitonininduced quiescence. J Cell Sci 1982; 57: 247-260 [PMID: 6759515]
45. Chambers TJ, Fuller K. Bone cells predispose bone surfaces to resorption by exposure of mineral to osteoclastic contact. J Cell Sci 1985; 76: 155-165 [PMID: 4066784]
46. Winick M. Nutrition and pregnancy. Pediatr Ann 1990; 19: 235-237 [PMID: 2188199 DOI: 10.1084/jem.164.1.104]
47. Thomson BM, Mundy GR, Chambers TJ. Tumor necrosis factors alpha and beta induce osteoblastic cells to stimulate osteoclastic bone resorption. J Immunol 1987; 138: 775-779 [PMID: 3805716]
48. Evely RS, Bonomo A, Schneider HG, Moseley JM, Gallagher J, Martin TJ. Structural requirements for the action of parathyroid hormone-related protein (PTHrP) on bone resorption by isolated osteoclasts. J Bone Miner Res 1991; 6: 85-93 [PMID: 2048435 DOI: 10.1002/jbmr.5650060114]
49. Chambers TJ. The pathobiology of the osteoclast. J Clin Pathol 1985; 38: 241-252 [PMID: 2982920 DOI: 10.1136/jcp.38.3.241]
50. Britto JM, Fenton AJ, Holloway WR, Nicholson GC. Osteoblasts mediate thyroid hormone stimulation of osteoclastic bone resorption. Endocrinology 1994; 134: 169-176 [PMID: 8275930 DOI: 10.1210/en.134.1.169]
51. McSheehy PM, Chambers TJ. Osteoblast-like cells in the presence of parathyroid hormone release soluble factor that stimulates osteoclastic bone resorption. Endocrinology 1986; 119: 1654-1659 [PMID: 3463505 DOI: 10.1210/endo-119-4-1654]
52. Perry HM, Skogen W, Chappel J, Kahn AJ, Wilner G, Teitelbaum SL. Partial characterization of a parathyroid hormonestimulated resorption factor(s) from osteoblast-like cells. Endocrinology 1989; 125: 2075-2082 [PMID: 2791978 DOI: 10.1210/endo-125-4-2075]
53. Fenton AJ, Martin TJ, Nicholson GC. Long-term culture of disaggregated rat osteoclasts: inhibition of bone resorption and reduction of osteoclast-like cell number by calcitonin and PTHrP[107-139]. J Cell Physiol 1993; 155: 1-7 [PMID: 8468357 DOI: 10.1002/jcp.1041550102]
54. Burger EH, van der Meer JW, Nijweide PJ. Osteoclast formation from mononuclear phagocytes: role of bone-forming cells. J Cell Biol 1984; 99: 1901-1906 [PMID: 6501407 DOI: 10.1083/jcb.99.6.1901]
55. Takahashi N, Yamana H, Yoshiki S, Roodman GD, Mundy GR, Jones SJ, Boyde A, Suda T. Osteoclast-like cell formation and its regulation by osteotropic hormones in mouse bone marrow cultures. Endocrinology 1988; 122: 1373-1382 [PMID: 3345718 DOI: 10.1210/endo-122-4-1373]
56. Suda T, Takahashi N, Martin TJ. Modulation of osteoclast differentiation. Endocr Rev 1992; 13: 66-80 [PMID: 1555533 DOI: 10.1210/edrv-13-1-66]
57. Takahashi N, Akatsu T, Udagawa N, Sasaki T, Yamaguchi A, Moseley JM, Martin TJ, Suda T. Osteoblastic cells are involved in osteoclast formation. Endocrinology 1988; 123: 2600-2602 [PMID: 2844518 DOI: 10.1210/endo-123-5-2600]
58. Udagawa N, Takahashi N, Akatsu T, Sasaki T, Yamaguchi A, Kodama H, Martin TJ, Suda T. The bone marrow-derived stromal cell lines MC3T3-G2/PA6 and ST2 support osteoclast-like cell differentiation in cocultures with mouse spleen cells. Endocrinology 1989; 125: 1805-1813 [PMID: 2676473 DOI: 10.1210/endo-125-4-1805]
59. Yamashita T, Asano K, Takahashi N, Akatsu T, Udagawa N, Sasaki T, Martin TJ, Suda T. Cloning of an osteoblastic cell line involved in the formation of osteoclast-like cells. J Cell Physiol 1990; 145: 587-595 [PMID: 1703173 DOI: 10.1002/jcp.1041450327]
60. Quinn JM, Horwood NJ, Elliott J, Gillespie MT, Martin TJ. Fibroblastic stromal cells express receptor activator of NFkappa B ligand and support osteoclast differentiation. J Bone Miner Res 2000; 15: 1459-1466 [PMID: 10934644 DOI: 10.1359/jbmr.2000.15.8.1459]
61. Yabe H, Matsushita A, Ichiba S, Nagai K, Nakayama S. [Myelodysplastic syndromes in two young brothers]. Rinsho Ketsueki 1992; 33: 184-188 [PMID: 1635166 DOI: 10.1172/JCI29463]
62. Nakashima T, Hayashi M, Fukunaga T, Kurata K, Oh-Hora M, Feng JQ, Bonewald LF, Kodama T, Wutz A, Wagner EF, Penninger JM, Takayanagi H. Evidence for osteocyte regulation of bone homeostasis through RANKL expression. Nat Med 2011; 17: 1231-1234 [PMID: 21909105 DOI: 10.1038/nm.2452]
63. Ménard J, Brunner HR, Waeber B, Plouin PF, Burnier M. Individualization of antihypertensive therapy. Hypertension 1988; 12: 526-528 [PMID: 3192296 DOI: 10.1038/nm.2448]
64. Beseda I, Vál'ka J. [Evaluation of metabolic profile tests using a computer]. Vet Med (Praha) 1977; 22: 705-712 [PMID: 24916]
65. Akatsu T, Takahashi N, Udagawa N, Sato K, Nagata N, Moseley JM, Martin TJ, Suda T. Parathyroid hormone (PTH)-related protein is a potent stimulator of osteoclast-like multinucleated cell formation to the same extent as PTH in mouse marrow cultures. Endocrinology 1989; 125: 20-27 [PMID: 2544401 DOI: 10.1210/endo-125-1-20]
66. Akatsu T, Takahashi N, Udagawa N, Imamura K, Yamaguchi A, Sato K, Nagata N, Suda T. Role of prostaglandins in interleukin-1-induced bone resorption in mice in vitro. J Bone Miner Res 1991; 6: 183-189 [PMID: 2028836 DOI: 10.1002/jbmr.5650060212]
67. Tamura T, Udagawa N, Takahashi N, Miyaura C, Tanaka S, Yamada Y, Koishihara Y, Ohsugi Y, Kumaki K, Taga T. Soluble interleukin-6 receptor triggers osteoclast formation by interleukin 6. Proc Natl Acad Sci USA 1993; 90: 11924-11928 [PMID: 8265649 DOI: 10.1073/pnas.90.24.11924]
68. Chambers TJ, Owens JM, Hattersley G, Jat PS, Noble MD. Generation of osteoclast-inductive and osteoclastogenic cell lines from the H-2KbtsA58 transgenic mouse. Proc Natl Acad Sci USA 1993; 90: 5578-5582 [PMID: 8390670]
69. Takahashi N, Udagawa N, Akatsu T, Tanaka H, Shionome M, Suda T. Role of colony-stimulating factors in osteoclast development. J Bone Miner Res 1991; 6: 977-985 [PMID: 1724107 DOI: 10.1002/jbmr.5650060912]
70. Tanaka S, Takahashi N, Udagawa N, Tamura T, Akatsu T, Stanley ER, Kurokawa T, Suda T. Macrophage colonystimulating factor is indispensable for both proliferation and differentiation of osteoclast progenitors. J Clin Invest 1993; 91: 257-263 [PMID: 8423223 DOI: 10.1172/JCI116179]
71. Hattersley G, Dorey E, Horton MA, Chambers TJ. Human macrophage colony-stimulating factor inhibits bone resorption by osteoclasts disaggregated from rat bone. J Cell Physiol 1988; 137: 199-203 [PMID: 3262621 DOI: 10.1002/jcp.1041370125]
72. Vignadndra V, Ghee LT, Chawla J. EEG in brain abscess: its value in localization compared to other diagnostic tests. Electroencephalogr Clin Neurophysiol 1975; 38: 611-622 [PMID: 50187]
73. Lorenzo JA, Sousa SL, Alander C, Raisz LG, Dinarello CA. Comparison of the bone-resorbing activity in the supernatants from phytohemagglutinin-stimulated human peripheral blood mononuclear cells with that of cytokines through the use of an antiserum to interleukin 1. Endocrinology 1987; 121: 1164-1170 [PMID: 3497797 DOI: 10.1210/endo-121-3-1164]
74. Loche D, Revol M. Proceedings: Definition, morphological and anatomical study of epileptic foci without apparent clinical manifestation. Electroencephalogr Clin Neurophysiol 1975; 39: 553-554 [PMID: 52536]
75. Lee MY, Lottsfeldt JL, Fevold KL. Identification and characterization of osteoclast progenitors by clonal analysis of hematopoietic cells. Blood 1992; 80: 1710-1716 [PMID: 1391940]
76. Kurihara N, Suda T, Miura Y, Nakauchi H, Kodama H, Hiura K, Hakeda Y, Kumegawa M. Generation of osteoclasts from isolated hematopoietic progenitor cells. Blood 1989; 74: 1295-1302 [PMID: 2669999]
77. Kurihara N, Chenu C, Miller M, Civin C, Roodman GD. Identification of committed mononuclear precursors for osteoclast-like cells formed in long term human marrow cultures. Endocrinology 1990; 126: 2733-2741 [PMID: 2184023 DOI: 10.1210/endo-126-5-2733]
78. Simonet WS, Lacey DL, Dunstan CR, Kelley M, Chang MS, Lüthy R, Nguyen HQ, Wooden S, Bennett L, Boone T, Shimamoto G, DeRose M, Elliott R, Colombero A, Tan HL, Trail G, Sullivan J, Davy E, Bucay N, Renshaw-Gegg L, Hughes TM, Hill D, Pattison W, Campbell P, Sander S, Van G, Tarpley J, Derby P, Lee R, Boyle WJ. Osteoprotegerin: a novel secreted protein involved in the regulation of bone density. Cell 1997; 89: 309-319 [PMID: 9108485 DOI: 10.1016/S0092-8674(00)80209-3]
79. Tsuda E, Goto M, Mochizuki S, Yano K, Kobayashi F, Morinaga T, Higashio K. Isolation of a novel cytokine from human fibroblasts that specifically inhibits osteoclastogenesis. Biochem Biophys Res Commun 1997; 234: 137-142 [PMID: 9168977 DOI: 10.1006/bbrc.1997.6603]
80. Lacey DL, Erdmann JM, Teitelbaum SL, Tan HL, Ohara J, Shioi A. Interleukin 4, interferon-gamma, and prostaglandin E impact the osteoclastic cell-forming potential of murine bone marrow macrophages. Endocrinology 1995; 136: 2367-2376 [PMID: 7750457 DOI: 10.1210/en.136.6.2367]
81. Yasuda H, Shima N, Nakagawa N, Yamaguchi K, Kinosaki M, Mochizuki S, Tomoyasu A, Yano K, Goto M, Murakami A, Tsuda E, Morinaga T, Higashio K, Udagawa N, Takahashi N, Suda T. Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL. Proc Natl Acad Sci USA 1998; 95: 3597-3602 [PMID: 9520411 DOI: 10.1073/pnas.95.7.3597]
82. Horwood NJ, Elliott J, Martin TJ, Gillespie MT. Osteotropic agents regulate the expression of osteoclast differentiation factor and osteoprotegerin in osteoblastic stromal cells. Endocrinology 1998; 139: 4743-4746 [PMID: 9794488 DOI: 10.1210/en.139.11.4743]
83. Udawela M, Hay DL, Sexton PM. The receptor activity modifying protein family of G protein coupled receptor accessory proteins. Semin Cell Dev Biol 2004; 15: 299-308 [PMID: 15125893 DOI: 10.1016/j.semcdb.2003.12.019]
84. Suda T, Takahashi N, Udagawa N, Jimi E, Gillespie MT, Martin TJ. Modulation of osteoclast differentiation and function by the new members of the tumor necrosis factor receptor and ligand families. Endocr Rev 1999; 20: 345-357 [PMID: 10368775 DOI: 10.1210/er.20.3.345]
85. Jimi E, Akiyama S, Tsurukai T, Okahashi N, Kobayashi K, Udagawa N, Nishihara T, Takahashi N, Suda T. Osteoclast differentiation factor acts as a multifunctional regulator in murine osteoclast differentiation and function. J Immunol 1999; 163: 434-442 [PMID: 10384146]
86. Lacey DL, Timms E, Tan HL, Kelley MJ, Dunstan CR, Burgess T, Elliott R, Colombero A, Elliott G, Scully S, Hsu H, Sullivan J, Hawkins N, Davy E, Capparelli C, Eli A, Qian YX, Kaufman S, Sarosi I, Shalhoub V, Senaldi G, Guo J, Delaney J, Boyle WJ. Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation. Cell 1998; 93: 165-176 [PMID: 9568710 DOI: 10.1016/S0092-8674(00)81569-X]
87. Wong BR, Josien R, Lee SY, Sauter B, Li HL, Steinman RM, Choi Y. TRANCE (tumor necrosis factor [TNF]-related activation-induced cytokine), a new TNF family member predominantly expressed in T cells, is a dendritic cell-specific survival factor. J Exp Med 1997; 186: 2075-2080 [PMID: 9396779 DOI: 10.1084/jem.186.12.2075]
88. Anderson DM, Maraskovsky E, Billingsley WL, Dougall WC, Tometsko ME, Roux ER, Teepe MC, DuBose RF, Cosman D, Galibert L. A homologue of the TNF receptor and its ligand enhance T-cell growth and dendritic-cell function. Nature 1997; 390: 175-179 [PMID: 9367155 DOI: 10.1038/36593]
89. Quinn JM, Neale S, Fujikawa Y, McGee JO, Athanasou NA. Human osteoclast formation from blood monocytes, peritoneal macrophages, and bone marrow cells. Calcif Tissue Int 1998; 62: 527-531 [PMID: 9576981 DOI: 10.1007/s002239900473]
90. Matsuzaki K, Udagawa N, Takahashi N, Yamaguchi K, Yasuda H, Shima N, Morinaga T, Toyama Y, Yabe Y, Higashio K, Suda T. Osteoclast differentiation factor (ODF) induces osteoclast-like cell formation in human peripheral blood mononuclear cell cultures. Biochem Biophys Res Commun 1998; 246: 199-204 [PMID: 9600092 DOI: 10.1006/bbrc.1998.8586]